Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2023.12.05.570305

Identification of candidate biomarkers and pathways associated with multiple sclerosis using bioinformatics and next generation sequencing data analysis

Vastrad, B. M.·Vastrad, C. M.
View original source ↗Export metadata ↓

Abstract

Multiple sclerosis (MS) is an autoinflammatory disease that might lead to severe disability. The diagnosis of MS is defined due to the urgency for biomarkers with both reliability and efficiency. Demyelination of axons are deeply involved in the pathogenesis of MS. Our study aims to identify the underlying molecular mechanism and screening for related biomarkers and signaling pathways. We obtained next generation sequencing (NGS) dataset (GSE138614) from the GEO database. Differentially expressed genes (DEGs) were screened by the DESeq2 package in R bioconductor with considering specific criteria. Gene Ontology (GO) enrichment analysis, REACTOME pathway enrichment analysis were performed; a protein-protein interaction (PPI) network was constructed; significant modules were analyzed and hub genes were identified by Human Integrated Protein-Protein Interaction rEference (HiPPIE). Subsequently, miRNA-hub gene regulatory network, TF-hub gene regulatory network and drug-hub gene interaction network were built by Cytoscape to predict the underlying microRNAs (miRNAs), transcription factors (TFs) and drugs associated with hub genes. Receiver operating characteristic (ROC) curves analysis was performed to calculate diagnostic value of hub genes. Finally, we performed molecular docking study for prediction of drug molecules against protein targets. A total of 959 DEGs (479 up-regulated and 480 down-regulated genes) were identified in the MS samples and compared with normal control samples. The DEGs were predominantly enriched in an ensemble of genes encoding the immune system process, developmental process, immune system and regulation of cholesterol biosynthesis by SREBP (SREBF). A PPI network was obtained through HiPPIE analysis, and the results were imported into Cytoscape software. The DEGs were sequenced by the Network Analyzer plug-in by various calculation methods, and 10 hub genes (LCK, PYHIN1, SLAMF1, DOK2, TAB2, CFTR, RHOB, LMNA, EGLN3 and ERBB3) were finally selected. Based on the miRNA-hub gene regulatory network and TF-hub gene regulatory network construction, miRNAs including hsa-mir-6794-3p, hsa-mir-3689a-3p, hsa-mir-4651, hsa-mir-548q, BRCA1, HNF4A, TFAP2C and NR2F1 were determined to be potential key biomarkers. Drug-hub gene interaction network constructed from DrugBank, which identified targeted therapeutic drugs (Palivizumab, Cu-Bicyclam, Lumacaftor and Zonisamide) for the hub genes. From molecular docking study we showed good drug - protein bind affinity and amino acid interactions. This study identified novel biomarkers for MS and established a reliable diagnostic model as well as predicted novel drug molecules. The transcriptional changes identified may help to reveal the pathogenesis and molecular mechanisms of MS.

Explore related subjects

bioinformaticsPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Vastrad, B. M., Vastrad, C. M.. 2023-12-07. Identification of candidate biomarkers and pathways associated with multiple sclerosis using bioinformatics and next generation sequencing data analysis. https://doi.org/10.1101/2023.12.05.570305

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

deepTools4: Faster, Scalable, and Modernized Genomic Data Analysis

The deepTools suite is widely used for quality control, summarization, and visualization of high-throughput sequencing data. However, as genomic datasets grow in scale and depth, existing tools often become computational bottlenecks. We present deepTools4, a modernized framework designed for high performance, scalability, and enhanced usability, while maintaining seamless integration with the Galaxy platform. Core functionality has been rewritten and thoroughly benchmarked, achieving substantial computational speed-ups. Visualization tools have been modernized to provide more intuitive, high-quality graphical outputs. In addition, our testing framework has been expanded to facilitate continuous development and ensure robustness. We demonstrate the utility of deepTools4 across diverse epigenomics and transcriptomics datasets, highlighting its ability to summarize genome-wide signals, apply a wide range of common normalization methods, and visualize enrichment patterns. The enhanced deepTools4 framework delivers a faster, more scalable solution for reproducible genome-wide analysis and interpretation across many sequencing modalities. Availability: https://github.com/deeptools/deepTools/

bioinformatics↗
bioRxiv2026

Reproducibility and cross-dataset concordance of drug-induced transcriptional responses

Drug-perturbation transcriptomic resources are expanding, but the reproducibility and cross-source consistency of the responses they measure remain critical to their use. We compared six resources using independent replicates, matched-drug analyses, and response decomposition. High agreement in treated expression did not translate into equally repeatable drug-induced changes. Cross-source response concordance was generally limited, including under matched cell and treatment conditions, although some comparisons retained drug-specific information. In Tahoe, a control-expression-only baseline left substantial drug-specific variation unresolved. Measured drug main effects - the average responses across cell lines - provided information for predicting cell-specific interactions, with this relationship retained in a cross-plate validation. Exploratory analyses of structure, target, and external-response representations identified modest signals in selected pipelines. Together, these analyses characterize the reliability and transferability of current perturbation resources and identify prediction of drug main effects as a key bottleneck in the framework examined, motivating shared reference measurements and better recovery of drug-specific responses.

bioinformatics↗
bioRxiv2026

Propensity-Adjusted AUC under Nuisance-Model Misspecification

Propensity adjustment compares medical-image detector scores within groups with similar measured properties, such as stain or focus. We examine its sensitivity to the nuisance model that forms those groups. Under Gaussian latent-index assumptions and exact linear-index strata, a closed-form correlation gives an exact boundary for adjusted AUC to fall below one half. Quadrature matches 36 simulation cells within 0.008. Inflation and attenuation relative to correct adjustment are empirical findings, not general ordering results. An overlap screen and a self-stratified control introduced for this study miss 140 of 141 simulated cells with absolute error above 0.05: checking the fitted propensity cannot certify completeness of the adjustment set. On real pathology corpora, logistic and boosted-tree models using the same 16 features disagree. Among splits where both pass both checks, mean adjusted-AUC gaps are 0.057 on acid-fast bacilli (AFB), 0.048 on Kaggle, and 0.049 on PCam, over three, five, and three splits respectively. These gaps measure model sensitivity; neither estimate is known to be correct. A controlled colour shift moves adjusted AUC relative to model-specific references in the predicted direction in 78 of 80 label-dependent cells. Broader balance and label-fit diagnostics favour trees without certifying their adjusted AUC. We recommend reporting sensitivity across nuisance models alongside these diagnostics. Reversal relative to known truth occurs in constructed stress tests; its frequency in practice remains unknown.

bioinformatics↗